Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10548988 Compounds for targeted immunotherapy

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 11 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 11 Dec, 2023
Edits made to:
Article (+454 characters)
Article

Patent abstract

Compounds for targeted immunotherapy, compositions comprising the compounds and use of the compounds in the treatment of diseases such as cancer are disclosed. The compounds having the structure of formula TM-Ln-AM, wherein TM is a targeting moiety, AM is an activating moiety that is capable of activating a human dendritic cell, NK cell, or tumor cell, or a combination thereof, Ln is a linker, and n is an integer selected from 0 and 1.

Edits on 7 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11834448 2-amino-quinoline derivatives
0
Edits on 18 Oct, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 18 Oct, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11786604 Compounds and compositions for treating HER2 positive tumors
Edits on 30 Apr, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Apr, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11633495 Compounds and compositions for immunotherapy
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Apr, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11633494 Compounds and compositions for immunotherapy
0
Edits on 5 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 5 Apr, 2023
Infobox
Patent Citations Received
‌
US Patent 11517567 Pharmaceutical compositions
0
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 4 Apr, 2023
Edits on 1 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 1 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
105489880
Date of Patent
February 4, 2020
0
Patent Application Number
158494360
Date Filed
December 20, 2017
0
Patent Citations Received
‌
US Patent 11400164 Immunoconjugates targeting HER2
0
‌
US Patent 11517567 Pharmaceutical compositions
0
‌
US Patent 11547761 Antibody adjuvant conjugates
0
Patent Primary Examiner
‌
Shulamith H. Shafer
0
Edits on 11 Jan, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Jan, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11547761 Antibody adjuvant conjugates
0
Edits on 7 Dec, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11517567 Pharmaceutical compositions
0
Edits on 25 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
105489880
Date of Patent
February 4, 2020
0
Patent Application Number
158494360
Date Filed
December 20, 2017
0
Patent Citations Received
‌
US Patent 11400164 Immunoconjugates targeting HER2
0
Patent Primary Examiner
‌
Shulamith H. Shafer
0
Edits on 3 Aug, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 3 Aug, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11400164 Immunoconjugates targeting HER2
Edits on 1 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 1 Feb, 2022
Edits made to:
Infobox (+7 properties)
‌

 US Patent 10548988 Compounds for targeted immunotherapy

Infobox
Is a
Patent
Patent
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10548988
Date of patent
February 4, 2020
Patent application number
15849436
Date Filed
December 20, 2017
Patent primary examiner
‌
Shulamith H. Shafer

Find more entities like US Patent 10548988 Compounds for targeted immunotherapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo